FDA
approval
· 2017-12-22
FDA Approved: TAZAROTENE — Original Application (Mayne Pharma)
Summary
FDA approved Mayne Pharma's original ANDA for tazarotene, enabling the generic topical retinoid product to enter the market.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TAZAROTENE (TAZAROTENE)